Bronchiolitis obliterans syndrome in lung transplant recipients is associated with increased neutrophil activity and decreased antioxidant statue in the lung

European Respiratory Journal

Volumn 12, Issue 1, 1998, Pages 82-88

  Riise, G C ^a   Williams, A ^b   Kjellstrom C ^a   Schersten, H ^a   Andersson, B A ^c   Kelly, F J ^b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Antixoidants; Bronchiolitis obliterans syndrome; Interleukin 8; Lung transplantation; Myeloperoxidase; Neutrophils

Indexed keywords

ANTIOXIDANT; BIOCHEMICAL MARKER; EOSINOPHIL CATIONIC PROTEIN; INTERLEUKIN 8; MYELOPEROXIDASE;

ADULT; AIRWAY OBSTRUCTION; ARTICLE; BRONCHIOLITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; EOSINOPHIL; FEMALE; HEART LUNG TRANSPLANTATION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; LEUKOCYTE ACTIVATION; LUNG LAVAGE; LUNG TRANSPLANTATION; MALE; PRIORITY JOURNAL; TRANSBRONCHIAL BIOPSY;

ADOLESCENT; ADULT; ANTIOXIDANTS; BIOPSY; BRONCHIOLITIS OBLITERANS; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; HEART-LUNG TRANSPLANTATION; HUMANS; LUNG; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; NEUTROPHIL ACTIVATION; NEUTROPHILS; POSTOPERATIVE COMPLICATIONS;

EID: 0031840788     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.98.12010082     Document Type: Article

References (22)

1. Bando K, Paradis I, Similo S, et al. Obliterative bronchiolitis after lung and heart-lung transplantation. J Thoracic Cardiovasc Surg 1995; 110: 4-14.
2. Yousem SA, Berry G, Brunt E, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: lung rejection study group. J Heart Transplant 1990; 9: 593-601.
3. Cooper JD, Billingham M, Egan T, et al. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. J Heart Lung Transplant 1993; 12: 713-716.
4. Kramer MR, Stoehr C, Whang JL, et al. The diagnosis of obliterative bronchiolitis after heart-lung and lung transplantation: low yield of transbronchial lung biopsy. J Heart Lung Transplant 1993; 12: 675-681.
5. Riise GC, Kjellström C, Ryd W, et al. Inflammatory cells and activation markers in BAL during acute rejection and infection in lung transplant recipients: a prospective, longitudinal study. Eur Respir J 1997; 10: 1742-1746.
6. Baz MA, Tapson VF, Roggli VL, Trigt PV, Piantadosi CA. Glutathione depletion in epithelial lining fluid of lung allograft patients. Am J Respir Crit Care Med 1996; 153: 742-746.
7. Williams A, Riise GC, Andersson B, Kjellström C, Schersten H, Kelly F. Compromised antioxidant status of lung transplant recipients. Eur Respir J (submitted).
8. DiGiovine B, Lynch JPR, Martinez FJ, et al. Bronchoalveolar lavage neutrophilia is associated with obliterative bronchiolitis after lung transplantation: role of IL-8. J Immunol 1996; 157: 4194-4202.
9. Riise GC, Schersten H, Nilsson FN, Ryd W, Andersson B. Activation of eosinophils and fibroblasts assessed by eosinophil cationic protein and hyaluronan in BAL. Association with acute rejection in lung transplant recipients. Chest 1996; 110: 89-96.
10. Ljungman P, Griffiths P. Definitions of cytomegalovirus infection and disease. In: Michelson S, Plotkin S, eds. Multidisciplinary Approach to Understanding Cytomegalovirus Disease. Amsterdam, Excerpta Medica, 1993; pp. 233-237.
11. Hsu S, Raine L, Fanger H. Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques. A comparison between ABC and unlabelled antibody (PAP). J Histochem Cytochem 1981; 29: 577-580.
12. Peterson CGB, Jömvall H, Venge P. Purification and characterization of eosinophil cationic protein from normal human eosinophils. Eur J Haematol 1988; 40: 415-423.
13. Venge P, Strömberg A, Braconier JH, Roxin LE, Olsson I. Neutrophil and eosinophil granulocytes in bacterial infection. Sequential studies of cellular and serum levels of granule proteins. Br J Haematol 1978; 38: 475-483.
14. Iriyama K, Yoshiura M, Iwamoto T, Ozaki Y. Simultaneous determination of uric acid and ascorbic acids in human serum by reversed-phase high-performance liquid chromatography with electrochemical detection. Anal Biochem 1984; 141: 238-243.
15. Kelly FJ, Blomberg A, Frew AJ, Holgate ST, Sandstrom T. Antioxidant kinetics in lung lining fluid following exposure of humans to nitrogen dioxide. Am J Respir Crit Care Med 1996; 154: 1700-1705.
16. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione. Anal Biochem 1969; 27: 502-522.
17. Griffith BP, Paradis IL, Zeevi A, et al. Immunologically mediated disease of the airways after pulmonary transplantation. Ann Surg 1988; 208: 371-378.
18. Maurer JR, Gouch E, Chamberlain DW, Patterson GA, Grossman RF. Sequential bronchoalveolar lavage studies from patients undergoing double lung and heart-lung transplant. Transplant Proc 1989; 21: 2585-2587.
19. Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptide-1/interleukin-8, a novel cytokine that activates neutrophils. J Clin Invest 1989; 84: 1045-1049.
20. Shute J. Interleukin-8 is a potent eosinophil chemo-attractant. Clin Exp Allergy 1994; 24: 203-206.
21. Riise GC, Ahlstedt S, Larsson S, et al. Bronchial inflammation in chronic bronchitis assessed by measurement of cell products in bronchial lavage fluid. Thorax 1995; 50: 360-365.
22. Stocker R, Frei B. Endogenous antioxidant defences in human blood plasma. New York, Academic Press, 1991; pp. 213-243.